| Original language | English |
|---|---|
| Pages (from-to) | 2073-2077 |
| Journal | Allergy |
| Volume | 75 |
| Issue number | 8 |
| Early online date | 2020 |
| DOIs |
|
| Publication status | Published - Aug 2020 |
Keywords
- Bet v 1
- birch pollen allergy
- immunotherapy
- mouse model
- retinoic acid
Retinoic acid-loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: in silico, in vitro and in vivo data in BALB/c mice
Karin Hufnagl, Sheriene Moussa Afify, Nina Braun, Stefanie Wagner, Michael Wallner, Michael Hauser, Markus Wiederstein, Gabriele Gadermaier, Sabrina Wildner, Frank A Redegeld, Bart R Blokhuis, Gerlinde Hofstetter, Isabella Pali-Schöll, Franziska Roth-Walter, Luis F Pacios, Erika Jensen-Jarolim
- Comparative Medicine, the interuniversity Messerli Research Institute of the University of Veterinary Medicine, the Medical University of Vienna and the University of Vienna, Vienna, Austria.
- Laboratory Medicine and Immunology Department, Faculty of Medicine, Menoufia University, Egypt, Shebin El-Kom.
- Department of Biosciences, University of Salzburg, Salzburg, Austria.
- Protein Bioinformatics Research Group, Department of Biosciences, University of Salzburg, Austria, Salzburg.
- University Medical Center Utrecht
- Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review